Otezla (apremilast) — Blue Cross Blue Shield of Montana
Quantity limit exception
Initial criteria
- 1. The requested quantity (dose) does NOT exceed the program quantity limit OR
- 2. The requested quantity (dose) exceeds the program quantity limit AND ONE of the following:
- A. BOTH of the following: (1) The requested agent does NOT have a maximum FDA labeled dose for the indication AND (2) There is support for therapy with a higher dose for the indication (submitted trials or guidelines required)
- OR
- B. BOTH of the following: (1) The requested quantity does NOT exceed the maximum FDA labeled dose for the indication AND (2) The requested quantity cannot be achieved with a lower quantity of a higher strength that does not exceed the program limit
- OR
- C. BOTH of the following: (1) The requested quantity exceeds the maximum FDA labeled dose for the requested indication AND (2) There is support for therapy with a higher dose (submitted trials or guidelines required)
Approval duration
12 months